UMIN ID: UMIN000002440
Registered date:01/10/2009
The effect of Ezetimibe in hypercholesterolemic patients with Nonaicoholic fatty liver disease(NAFLD)
Basic Information
Recruitment status | Complete: follow-up continuing |
---|---|
Health condition(s) or Problem(s) studied | Nonaicoholic fatty liver disease |
Date of first enrollment | 2008/01/01 |
Target sample size | 50 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Ezetimibe |
Outcome(s)
Primary Outcome | 1) Histological and immunohistochemical analysis of analysis of liver 2) L/S ratio by CT 3) Various biological markers of liver didease. |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1.patients being taken Ezetimibe 2.patients with serious liver disease 3.secondary hyperlipidemia or drug-induced hyperlipidemia 4.pregnant or lactating women 5.aicoholconsumption>21g/day |
Related Information
Primary Sponsor | Saiseikai Suita Hospital |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | None |
Secondary ID(s) |
Contact
public contact | |
Name | |
Address | Japan |
Telephone | |
parkh50@hotmail.com | |
Affiliation | Saiseikai Suita Hospital Internal medicine |
scientific contact | |
Name | Takeshi Okanoue |
Address | 1-2 Kawazonocho, Suita, 564-0013, Japan Japan |
Telephone | |
Affiliation | Saiseikai Suita Hospital Gastroenterology and Hepatology |